DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

UPDATE: Acasti Says Plans To Seek FDA Guidance Prior To Unblinding TRILOGY 2 Data, Expected To Delay Reporting To Topline Results Until Calendar Q3'20

Benzinga · 02/10/2020 12:08